| Variable | FA paroxística (n=10)1 | FA persistente/persistente larga (n=10)1 | Total AVP (n=20)1 | p2 |
|---|---|---|---|---|
| Betabloqueador oral, uso n (%) | 10 (100%) | 10 (100%) | 20 (100%) | |
| Antiarritmico, uso n (%) | 10 (100%) | 10 (100%) | 20 (100%) | |
| Anticoagulante, uso n (%) | 10 (100%) | 10 (100%) | 20 (100%) | |
| Bisoprolol n (%) | 2 (20%) | 2 (20%) | 4 (20%) | >0.999 |
| Carvedilol n (%) | 2 (20%) | 1 (10%) | 3 (15%) | >0.999 |
| Metoprolol succinato n (%) | 6 (60%) | 7 (70%) | 13 (65%) | >0.999 |
| Ablación previa de FA n (%) | 10 (100%) | 10 (100%) | 20 (100%) | |
| Número de ablaciones previas | 1 (10%) | 2 (20%) | 3 (15%) | >0.999 |
| 1 n (%) | ||||
| 2 Fisher’s exact test | ||||